language-icon Old Web
English
Sign In
Acemap > Paper > A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours

A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours

2012 
A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours
Keywords:
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    37
    References
    127
    Citations
    NaN
    KQI
    []
    logo
    • CCF Conference Analysis
    • Map Galaxy
    • What's New
    © Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.